查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970834

代謝檢測市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、地區和競爭對手分類，2021-2031年

Metabolic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球代謝檢測市場預計將從 2025 年的 6.195 億美元成長到 2031 年的 8.3066 億美元，複合年成長率為 5.01%。

該領域涵蓋診斷軟體和設備，它們透過測量能量消耗和氧氣消耗等指標來評估生理健康狀況。市場成長的主要驅動力是慢性文明病疾病發生率的上升，以及代謝評估在健康計劃和運動醫學中日益普及。國際糖尿病聯盟在2024年發布的報告強調了精準代謝分析工具的重要性，報告預測全球約有5.89億成年人將患有糖尿病。

市場概覽
預測期 2027-2031
市場規模：2025年 6.195億美元
市場規模：2031年 8.3066億美元
複合年成長率：2026-2031年 5.01%
成長最快的細分市場 身體組成分析
最大的市場 北美洲

儘管成長要素強勁，但市場仍面臨許多障礙，例如先進檢測設備成本高昂以及需要專業培訓才能解讀數據。這些經濟和技術壁壘往往阻礙了新興經濟體的醫療機構和小規模診所採用這些先進系統。因此，這些限制阻礙了代謝檢測技術的廣泛應用，並成為全球市場更廣泛發展和擴張的主要障礙。

市場促進因素

全球肥胖和糖尿病的日益普及是推動市場成長的主要因素，也因此迫切需要能夠有效監測代謝健康並進行體重管理的先進診斷工具。隨著METABOLIC INC.症候群成為全球性流行病，個人和醫療保健機構都擴大轉向代謝檢測，以製定個人化的健身和營養策略。文明病的增加使得人們即時需要獲得關於基材利用和能量消耗的準確數據，以對抗慢性疾病。 2024年3月，世界肥胖聯盟強調了問題的嚴重性，估計全球有超過10億人肥胖。這意味著龐大的患者群體需要進行代謝干預。

同時，代謝監測設備的科技創新正在變革整個產業，將複雜的臨床診斷轉化為方便用戶使用、易於使用的穿戴式裝置。智慧戒指和連續血糖監測儀等設備能夠即時追蹤代謝指標，使用者群體也從精英運動員擴展到一般大眾。這種向個人化數據分析和遠端監測的轉變，正為製造商帶來巨大的商業性成功。例如，2024年10月，雅培公司報告稱，其FreeStyle Libre連續血糖監測系統僅在第三季的銷售額就超過16億美元，實現了19.1%的成長率。此外，2024年3月，《展望商業》報道稱，代謝追蹤Start-UpsUltrahuman獲得了3,500萬美元的B輪資金籌措，用於擴大其研發和生產能力，凸顯了該領域的蓬勃發展。

市場挑戰

全球代謝檢測市場成長的主要障礙在於先進檢測設備及其操作所需的專業培訓成本高昂。先進代謝測量設備所需的高額初始投資，對發展中地區的獨立診所、小規模醫療機構和醫療保健系統構成了巨大的進入門檻。因此，該市場主要局限於高階醫院和資金雄厚的研究機構，這極大地限制了潛在市場規模，並阻礙了該技術在普通臨床實踐中的廣泛應用。

聘用精通複雜代謝數據解讀的專家所帶來的營運成本，更加劇了醫療機構的財務負擔。高昂的營運成本和資本成本的雙重壓力，迫使許多醫療機構管理者降低了這些診斷工具的優先順序。這種財務保守主義也體現在近期的採購趨勢中。根據美國醫院協會 (AHA) 統計，94% 的醫療機構管理者預計到 2024 年將推遲設備升級，以應對日益成長的財務壓力。這種普遍推遲資本投資的做法，直接阻礙了代謝檢測市場的發展，抑制了尖端系統的採購，抵消了慢性文明病日益成長所帶來的需求。

市場趨勢

將人工智慧融入預測性代謝分析正在從根本上改變整個產業，使診斷方式從被動觀察轉變為動態疾病逆轉模擬。先進的演算法正在產生“數位雙胞胎”，以虛擬方式複製個體的代謝特徵，從而預測個體對特定生活方式調整的生理反應。這項創新使醫療服務提供者能夠超越傳統的靜態報告方法，推薦數據驅動的、可即時調整的精準干預措施。根據HLTH報道，為了支持這項技術進步，Twin Health於2025年8月資金籌措了5,300萬美元，用於擴展其人工智慧驅動的「全身數位雙胞胎」平台。該平台透過為每位成員提供個人化指導，幫助改善慢性代謝疾病。

同時，隨著代謝為基礎的精準營養理念的興起，市場關注點正從臨床糖尿病管理擴展到更廣泛的健康促進和體重管理應用。製造商和監管機構正擴大核准連續代謝監測用於一般用途，使消費者能夠利用即時血糖數據而非一般建議來調整飲食。這一趨勢正在推動專門核准用於非醫療體重管理的設備商業化，使代謝檢測有效地擺脫了對胰島素的依賴。根據 MedTech Dive 於 2025 年 8 月報道，Signos 公司一款專為體重管理設計的血糖監測系統獲得了 FDA 的核准，這標誌著一個重要的行業進展：向普通消費者市場提供易於獲取的商業化代謝分析資訊。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球代謝檢測市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品細分（CPET、身體組成分析、心電圖、可攜式系統）
    • 依應用領域（重症監護、文明病、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美代謝檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲代謝檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區代謝檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲代謝檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲代謝檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球代謝偵測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Becton, Dickinson and Company
  • General Electric Company
  • Geratherm Medical AG
  • MGC DIAGNOSTICS CORPORATION
  • OSI Systems, Inc.
  • CORTEX Biophysik GmbH
  • COSMED srl
  • KORR Medical Technology Inc.
  • Microlife Medical Home Solutions, Inc.
  • Parvomedics, Incorporated

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24553

The Global Metabolic Testing Market is projected to expand from USD 619.50 Million in 2025 to USD 830.66 Million by 2031, registering a compound annual growth rate of 5.01%. This sector comprises diagnostic software and devices designed to evaluate physiological health by measuring metrics such as energy expenditure and oxygen consumption. Market growth is largely sustained by the rising incidence of chronic lifestyle-related diseases and the increasing adoption of metabolic assessments within wellness programs and sports medicine. Highlighting the critical need for accurate metabolic profiling tools, the International Diabetes Federation reported in 2024 that approximately 589 million adults worldwide were living with diabetes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 619.50 Million
Market Size 2031USD 830.66 Million
CAGR 2026-20315.01%
Fastest Growing SegmentBody Composition Analysis
Largest MarketNorth America

Despite these robust growth drivers, the market faces significant hurdles stemming from the substantial costs associated with sophisticated testing equipment and the necessity for specialized training to interpret the data. These financial and technical barriers often prevent healthcare institutions and smaller clinics in emerging economies from implementing these advanced systems. Consequently, these constraints restrict the accessibility of metabolic testing technologies and serve as a major impediment to the broader development and expansion of the global market.

Market Driver

The rising global prevalence of obesity and diabetes serves as a major market accelerator, creating an urgent demand for sophisticated diagnostic tools capable of supporting effective metabolic health monitoring and weight management. With metabolic syndrome emerging as a worldwide epidemic, both individuals and healthcare providers are increasingly turning to metabolic testing to customize fitness and nutritional strategies. This escalation in lifestyle-related conditions necessitates immediate access to precise data on substrate utilization and energy expenditure to combat chronic illnesses. The World Obesity Federation emphasized the scale of this issue in March 2024, estimating that over one billion people worldwide are living with obesity, representing a massive patient population in need of metabolic intervention.

Concurrently, technological innovations in metabolic testing devices are transforming the industry by evolving complex clinical diagnostics into user-friendly, accessible wearable formats. Devices such as smart rings and continuous glucose monitors now enable real-time tracking of metabolic indicators, expanding the user base from elite athletes to the general public. This transition toward personalized data analytics and remote monitoring has generated significant commercial success for manufacturers. For instance, Abbott reported in October 2024 that sales of its FreeStyle Libre continuous glucose monitoring system surpassed $1.6 billion in the third quarter alone, reflecting a 19.1 percent growth. Furthermore, Outlook Business noted in March 2024 that the metabolic tracking startup Ultrahuman secured $35 million in Series B funding to expand its research and manufacturing capabilities, underscoring the sector's vitality.

Market Challenge

A significant impediment to the growth of the Global Metabolic Testing Market is the prohibitive cost linked to sophisticated testing equipment and the specialized training required for its use. The high initial capital investment needed for advanced metabolic measurement devices establishes a formidable entry barrier for independent clinics, smaller medical facilities, and healthcare systems in developing regions. As a result, the market remains largely confined to premium hospitals and well-funded research institutions, which effectively limits the total addressable market and decelerates the adoption of this technology in general clinical practice.

This financial strain is further exacerbated by the operational expenses associated with hiring skilled professionals competent in interpreting complex metabolic data. The combined weight of high operational and capital costs compels many healthcare administrators to lower the priority of these diagnostic tools. This fiscal conservatism is reflected in recent procurement trends; according to the American Hospital Association, 94% of healthcare administrators in 2024 expected to delay equipment upgrades to navigate rising financial pressures. Such widespread postponement of capital investments directly impedes the metabolic testing market by stalling the purchase of modern systems, thereby counteracting the demand generated by the increase in chronic lifestyle diseases.

Market Trends

The integration of artificial intelligence for predictive metabolic analytics is fundamentally transforming the industry by shifting diagnostics from passive observation to dynamic, disease-reversing simulations. Sophisticated algorithms now facilitate the generation of "digital twins"-virtual representations of an individual's specific metabolism-that forecast physiological reactions to particular lifestyle adjustments. This innovation empowers providers to recommend precise, data-informed interventions that adjust in real-time, surpassing traditional static reporting methods. Underscoring this technological advancement, Twin Health raised $53 million in August 2025, as reported by HLTH, to expand its Whole Body Digital Twin platform, which utilizes AI to assist members in reversing chronic metabolic diseases through tailored guidance.

Simultaneously, the emergence of metabolically-driven precision nutrition is broadening the market's focus from clinical diabetes management to wider wellness and weight control applications. Manufacturers and regulatory agencies are increasingly validating continuous metabolic monitoring for general use, allowing consumers to refine their diets using real-time glycemic data instead of generic recommendations. This trend has resulted in the commercialization of devices specifically approved for non-medical weight management, effectively separating metabolic testing from insulin dependence. In a notable industry development reported by MedTech Dive in August 2025, Signos received FDA clearance for its glucose monitoring system designed specifically for weight management, signaling a major shift toward providing accessible, over-the-counter metabolic insights to the mass market.

Key Market Players

  • Becton, Dickinson and Company
  • General Electric Company
  • Geratherm Medical AG
  • MGC DIAGNOSTICS CORPORATION
  • OSI Systems, Inc.
  • CORTEX Biophysik GmbH
  • COSMED srl
  • KORR Medical Technology Inc.
  • Microlife Medical Home Solutions, Inc.
  • Parvomedics, Incorporated

Report Scope

In this report, the Global Metabolic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Metabolic Testing Market, By Product

  • CPET
  • Body Composition Analysis
  • ECG
  • Portable System

Metabolic Testing Market, By Application

  • Critical Care
  • Lifestyle Diseases
  • Others

Metabolic Testing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Metabolic Testing Market.

Available Customizations:

Global Metabolic Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Metabolic Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (CPET, Body Composition Analysis, ECG, Portable System)
    • 5.2.2. By Application (Critical Care, Lifestyle Diseases, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Metabolic Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Metabolic Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Metabolic Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Metabolic Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Metabolic Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Metabolic Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France Metabolic Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Metabolic Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Metabolic Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Metabolic Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific Metabolic Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Metabolic Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Metabolic Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Metabolic Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Metabolic Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Metabolic Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa Metabolic Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Metabolic Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Metabolic Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Metabolic Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America Metabolic Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Metabolic Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Metabolic Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Metabolic Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Metabolic Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton, Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. General Electric Company
  • 15.3. Geratherm Medical AG
  • 15.4. MGC DIAGNOSTICS CORPORATION
  • 15.5. OSI Systems, Inc.
  • 15.6. CORTEX Biophysik GmbH
  • 15.7. COSMED srl
  • 15.8. KORR Medical Technology Inc.
  • 15.9. Microlife Medical Home Solutions, Inc.
  • 15.10. Parvomedics, Incorporated

16. Strategic Recommendations

17. About Us & Disclaimer